{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:10:24Z","timestamp":1783944624315,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":279,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Informatics in Medicine Unlocked"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.imu.2020.100446","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T08:22:13Z","timestamp":1602145333000},"page":"100446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio\/chemoinformatics tools"],"prefix":"10.1016","volume":"21","author":[{"given":"Rania M.","family":"Hathout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherihan G.","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2140-6395","authenticated-orcid":false,"given":"Abdelkader A.","family":"Metwally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imu.2020.100446_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejps.2019.03.016","article-title":"Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy","volume":"133","author":"Abdelrady","year":"2019","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.imu.2020.100446_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.colsurfb.2016.05.066","article-title":"Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7","volume":"145","author":"Abozeid","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.imu.2020.100446_bib3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-13-418","article-title":"Primaquine: the risks and the benefits","volume":"13","author":"Ashley","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.imu.2020.100446_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.imu.2020.100446_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10557-018-06847-9","article-title":"Revisiting the cardiotoxic effect of chloroquine","volume":"33","author":"Blignaut","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.imu.2020.100446_bib6","first-page":"2732017","article-title":"Inhaled therapy in respiratory disease: the complex interplay of pulmonary kinetic processes","author":"Borghardt","year":"2018","journal-title":"Can. Respir. J"},{"key":"10.1016\/j.imu.2020.100446_bib7","doi-asserted-by":"crossref","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.imu.2020.100446_bib8","doi-asserted-by":"crossref","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.imu.2020.100446_bib9","doi-asserted-by":"crossref","first-page":"105923","DOI":"10.1016\/j.ijantimicag.2020.105923","article-title":"Chloroquine for the 2019 novel coronavirus SARS-CoV-2","volume":"55","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.imu.2020.100446_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","author":"Cortegiani","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.imu.2020.100446_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcrc.2020.06.019","article-title":"Update I. A systematic review on the efficacy and safety of chloroquine\/hydroxychloroquine for COVID-19","volume":"59","author":"Cortegiani","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.imu.2020.100446_bib12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.colsurfb.2014.10.045","article-title":"Silencing of the scavenger receptor (Class B - type 1) gene using siRNA-loaded chitosan nanaoparticles in a HepG2 cell model","volume":"123","author":"Farid","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.imu.2020.100446_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.imu.2020.100446_bib14","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.imu.2020.100446_bib15","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imu.2020.100446_bib16","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of covid-19 in New York city","volume":"382","author":"Goyal","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imu.2020.100446_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1165\/rcmb.2016-0043TR","article-title":"Heparan sulfate in the developing, healthy, and injured lung","volume":"55","author":"Haeger","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.imu.2020.100446_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-018-1188-2","article-title":"The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review","volume":"16","author":"Haeusler","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.imu.2020.100446_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5114\/reum.2018.76904","article-title":"Antimalarials - are they effective and safe in rheumatic diseases?","volume":"56","author":"Haladyj","year":"2018","journal-title":"Reumatologia"},{"key":"10.1016\/j.imu.2020.100446_bib20","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1080\/14786419.2017.1385017","article-title":"Curcumin or bisdemethoxycurcumin for nose-to-brain treatment of Alzheimer disease? A bio\/chemo-informatics case study","volume":"32","author":"Hathout","year":"2018","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.imu.2020.100446_bib21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejpb.2016.07.019","article-title":"Towards better modelling of drug-loading in solid lipid nanoparticles: molecular dynamics, docking experiments and Gaussian Processes machine learning","volume":"108","author":"Hathout","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.imu.2020.100446_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-4939-9516-5_6","article-title":"Gelatin nanoparticles","author":"Hathout","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.imu.2020.100446_bib23","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1021\/acsomega.9b03487","article-title":"Prediction of drug loading in the gelatin matrix using computational methods","volume":"5","author":"Hathout","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.imu.2020.100446_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41565-020-0674-9","article-title":"Insights from nanomedicine into chloroquine efficacy against COVID-19","volume":"15","author":"Hu","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.imu.2020.100446_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.imu.2020.100446_bib26","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1128\/JVI.00253-07","article-title":"Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted","volume":"81","author":"Inoue","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.imu.2020.100446_bib27","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.imu.2020.100446_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00754-17","article-title":"Zinc salts block hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase","volume":"91","author":"Kaushik","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.imu.2020.100446_bib29","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/AAC.01509-08","article-title":"Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice","volume":"53","author":"Keyaerts","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.imu.2020.100446_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023710","article-title":"Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans","volume":"6","author":"Lang","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.imu.2020.100446_bib31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.imu.2020.100446_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.imu.2020.100446_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5582\/bst.2020.01020","article-title":"Drug treatment options for the 2019-new coronavirus (2019-nCoV)","volume":"14","author":"Lu","year":"2020","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.imu.2020.100446_bib34","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.imu.2020.100446_bib35","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.phymed.2016.10.020","article-title":"Selecting optimum protein nano-carriers for natural polyphenols using chemoinformatics tools","volume":"23","author":"Metwally","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.imu.2020.100446_bib36","doi-asserted-by":"crossref","first-page":"13221","DOI":"10.1128\/JVI.02078-14","article-title":"Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells","volume":"88","author":"Milewska","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.imu.2020.100446_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.devcel.2015.03.002","article-title":"CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature","volume":"33","author":"Miller","year":"2015","journal-title":"Dev Cell"},{"key":"10.1016\/j.imu.2020.100446_bib38","doi-asserted-by":"crossref","first-page":"11293","DOI":"10.1021\/acsomega.9b01580","article-title":"Enhanced allicin cytotoxicity on HEPG-2 cells using glycyrrhetinic acid surface-decorated gelatin nanoparticles","volume":"4","author":"Ossama","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.imu.2020.100446_bib39","doi-asserted-by":"crossref","first-page":"104904","DOI":"10.1016\/j.phrs.2020.104904","article-title":"The possible mechanisms of action of 4-aminoquinolines (chloroquine\/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): a role for iron homeostasis?","volume":"158","author":"Quiros Roldan","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.imu.2020.100446_bib40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.imu.2020.100446_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.rdc.2019.04.008","article-title":"Are the current recommendations for chloroquine and hydroxychloroquine screening appropriate?","volume":"45","author":"Schwartzman","year":"2019","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.imu.2020.100446_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2018.04.059","article-title":"Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: augmented in-vivo efficacy and safe histological profile","volume":"545","author":"Shokry","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.imu.2020.100446_bib43","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.imu.2020.100446_bib44","series-title":"Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers","year":"2005"},{"key":"10.1016\/j.imu.2020.100446_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"10.1016\/j.imu.2020.100446_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/156652306775515565","article-title":"Heparan sulphate proteoglycans and viral vectors : ally or foe?","volume":"6","author":"Vives","year":"2006","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.imu.2020.100446_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1526-0550(02)00007-0","article-title":"What does mucin have to do with lung disease?","volume":"3","author":"Voynow","year":"2002","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.imu.2020.100446_bib48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cr.2008.15","article-title":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.imu.2020.100446_bib49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.imu.2020.100446_bib50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.imu.2020.100446_bib51","doi-asserted-by":"crossref","first-page":"13738","DOI":"10.1038\/s41598-017-14221-2","article-title":"A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery","volume":"7","author":"Wolfram","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.imu.2020.100446_bib52","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.imu.2020.100446_bib53","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.imu.2020.100446_bib54","doi-asserted-by":"crossref","first-page":"19970","DOI":"10.1073\/pnas.0908837106","article-title":"Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor","volume":"106","author":"Wu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.imu.2020.100446_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jcph.391","article-title":"Dose escalation pharmacokinetics of intranasal scopolamine gel formulation","volume":"55","author":"Wu","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.imu.2020.100446_bib56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.imu.2020.100446_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109180","article-title":"Chloroquine is a zinc ionophore","volume":"9","author":"Xue","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.imu.2020.100446_bib58","doi-asserted-by":"crossref","first-page":"109802","DOI":"10.1016\/j.mehy.2020.109802","article-title":"Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19","volume":"144","author":"Yang","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.imu.2020.100446_bib59","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.imu.2020.100446_bib60","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/jac\/dkaa114","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","volume":"75","author":"Zhou","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.imu.2020.100446_bib61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.imu.2020.100446_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.imu.2020.100446_bib63","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3389\/fbioe.2020.00885","article-title":"Positively charged electroceutical spun chitosan nanofibers can protect health care providers from COVID-19 infection: An opinion","volume":"8","author":"Hathout","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.imu.2020.100446_bib64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.colsurfb.2018.03.051","article-title":"Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy","volume":"167","author":"Abdel-Hafez","year":"2018","journal-title":"Colloids Surf B Biointerfaces"}],"container-title":["Informatics in Medicine Unlocked"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352914820305967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352914820305967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:21:56Z","timestamp":1783941716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352914820305967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":64,"alternative-id":["S2352914820305967"],"URL":"https:\/\/doi.org\/10.1016\/j.imu.2020.100446","relation":{},"ISSN":["2352-9148"],"issn-type":[{"value":"2352-9148","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chloroquine and hydroxychloroquine for combating COVID-19: Investigating efficacy and hypothesizing new formulations using Bio\/chemoinformatics tools","name":"articletitle","label":"Article Title"},{"value":"Informatics in Medicine Unlocked","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imu.2020.100446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100446"}}